Clinical Trial Update: A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing dabigatran etexilate to warfarin in cerebral venous and dural sinus thrombosis has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Venous Sinus Thrombosis
• Cerebral Venous and Dural Sinus Thrombosis

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)
• Warfarin (warfarin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2019-08-15